ADVB

Advanced Biomed Inc. Common Stock (ADVB)

Stock · NASDAQ · Health Care

$9.59as of 8/28/2026

Active signals

Support level
$4.08
Industry
Medical Specialities

About ADVB

Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, an automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagulable state samples of…

Sector
Health Care
Industry
Medical Specialities
Employees
31

Fundamentals

1-day range
$6.37$7.42
Market cap
$12.29M
P/E (trailing)
2.68
P/E (forward)
EPS (trailing)
$4.95
Dividend yield
Beta
0.11
Avg. volume
1.72M
52-week range
$3.61$24.23

Advanced Biomed Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • ADVB
    Advanced Biomed Inc. Common Stock
    $9.7
    ▲ 1.36%
    Market cap $12.29MP/E 2.68
    $3.61$24.23
  • SERA
    Sera Prognostics Inc. Class A Common Stock
    $2.07
    ▲ 0.49%
    Market cap $78.32MP/E
    $1.56$3.95
  • BNR
    Burning Rock Biotech Limited American Depositary Shares
    $10.19
    ▲ 1.90%
    Market cap $93.65MP/E
    $6.79$41.72
  • KEQU
    Kewaunee Scientific Corporation Common Stock
    $37.78
    ▼ 0.50%
    Market cap $108.73MP/E 10.89
    $33.27$59
  • XGN
    Exagen Inc. Common Stock
    $7.38
    ▼ 1.86%
    Market cap $159.64MP/E
    $2.59$12.23
  • ACH
    Accendra Health Inc. Common Stock
    $1.22
    ▲ 0.83%
    Market cap $223.62MP/E
    $0.9337$5.69
  • BDSX
    Biodesix Inc. Common Stock
    $26.81
    ▼ 5.86%
    Market cap $228.86MP/E
    $5.26$31.31

P/E shows — for peers not currently carrying a live signal of their own.

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.